Becton Dickinson
1 Becton Dr, FRANKLIN LAKES, NJ, US
Registered product codes
52 product codes
Recent MDR events
156,076 on file
- BD Luer-LokJul 31, 2026Malfunction1213809-2026-00397
- BD BACTEC¿ MGIT¿ 960 InstrumentJul 31, 2026Malfunction1119779-2026-01375
- BD BACTEC¿ Plus Aerobic/F Culture Vials (plastic)Jul 31, 2026Malfunction2647876-2026-00087
- BD BACTEC¿ Plus Aerobic/F Culture Vials (plastic)Jul 31, 2026Malfunction2647876-2026-00086
- BD BACTEC¿ MGIT¿ 960 InstrumentJul 31, 2026Malfunction1119779-2026-01376
- Panel Phoenix NMIC/ID-483Jul 31, 2026Malfunction1119779-2026-01377
- BD Phoenix¿ M50 Automated Microbiology SystemJul 31, 2026Malfunction1119779-2026-01374
- Insyte AUTOGUARDJul 31, 2026Malfunction1710034-2026-00862
- Unknown 20ml BD SyringeJul 31, 2026Malfunction2243072-2026-00543
- Unknown 20 ML BD SyringeJul 31, 2026Malfunction2243072-2026-00542
Recalls
641 on file
- Open, ClassifiedMay 29, 2026
This is a sub-recall of a product recall from Huons Co, Ltd., the manufacturer of Bupivacaine Hydrochloride in Dextrose Injection, USP. The recall is due to quality issues identified during an FDA manufacturing facility inspection, citing specific quality deficiencies related to acceptance testing.
View FDA record ↗ - Open, ClassifiedMay 29, 2026
This is a sub-recall of a product recall from Huons Co, Ltd., the manufacturer of Bupivacaine Hydrochloride in Dextrose Injection, USP. The recall is due to quality issues identified during an FDA manufacturing facility inspection, citing specific quality deficiencies related to acceptance testing.
View FDA record ↗ - Open, ClassifiedMay 29, 2026
This is a sub-recall of a product recall from Huons Co, Ltd., the manufacturer of Bupivacaine Hydrochloride in Dextrose Injection, USP. The recall is due to quality issues identified during an FDA manufacturing facility inspection, citing specific quality deficiencies related to acceptance testing.
View FDA record ↗ - Open, ClassifiedMay 29, 2026
This is a sub-recall of a product recall from Huons Co, Ltd., the manufacturer of Bupivacaine Hydrochloride in Dextrose Injection, USP. The recall is due to quality issues identified during an FDA manufacturing facility inspection, citing specific quality deficiencies related to acceptance testing.
View FDA record ↗ - Open, ClassifiedMay 29, 2026
This is a sub-recall of a product recall from Huons Co, Ltd., the manufacturer of Bupivacaine Hydrochloride in Dextrose Injection, USP. The recall is due to quality issues identified during an FDA manufacturing facility inspection, citing specific quality deficiencies related to acceptance testing.
View FDA record ↗ - Open, ClassifiedMay 29, 2026
This is a sub-recall of a product recall from Huons Co, Ltd., the manufacturer of Bupivacaine Hydrochloride in Dextrose Injection, USP. The recall is due to quality issues identified during an FDA manufacturing facility inspection, citing specific quality deficiencies related to acceptance testing.
View FDA record ↗ - Open, ClassifiedMay 29, 2026
This is a sub-recall of a product recall from Huons Co, Ltd., the manufacturer of Bupivacaine Hydrochloride in Dextrose Injection, USP. The recall is due to quality issues identified during an FDA manufacturing facility inspection, citing specific quality deficiencies related to acceptance testing.
View FDA record ↗ - Open, ClassifiedMay 29, 2026
This is a sub-recall of a product recall from Huons Co, Ltd., the manufacturer of Bupivacaine Hydrochloride in Dextrose Injection, USP. The recall is due to quality issues identified during an FDA manufacturing facility inspection, citing specific quality deficiencies related to acceptance testing.
View FDA record ↗ - Open, ClassifiedMay 29, 2026
This is a sub-recall of a product recall from Huons Co, Ltd., the manufacturer of Bupivacaine Hydrochloride in Dextrose Injection, USP. The recall is due to quality issues identified during an FDA manufacturing facility inspection, citing specific quality deficiencies related to acceptance testing.
View FDA record ↗ - Open, ClassifiedMay 29, 2026
This is a sub-recall of a product recall from Huons Co, Ltd., the manufacturer of Bupivacaine Hydrochloride in Dextrose Injection, USP. The recall is due to quality issues identified during an FDA manufacturing facility inspection, citing specific quality deficiencies related to acceptance testing.
View FDA record ↗
Compliance history
Matched by FEI 2243072.
FDA inspections
0 on file
No inspections on file for this FEI number.
Inspection citations
0 on file
No citations on file for this FEI number.
Compliance actions
0 on file
No warning letters or injunctions on file for this FEI number.
Import refusals
11 on file
Top refusal reasons
Compare to industry ↗- Division of Southeast Imports (DSEI)Jun 1, 2026
80FMF \ SYRINGE, PISTON
- Division of Southeast Imports (DSEI)Oct 9, 2025
80FMI \ NEEDLE, HYPODERMIC, SINGLE LUMEN
- Division of Southeast Imports (DSEI)May 27, 2025
80FMF \ SYRINGE, PISTON
- Division of Southeast Imports (DSEI)May 2, 2025
80FMI \ NEEDLE, HYPODERMIC, SINGLE LUMEN
- Division of Southeast Imports (DSEI)May 2, 2025
80FMI \ NEEDLE, HYPODERMIC, SINGLE LUMEN
- Division of Southeast Imports (DSEI)Apr 28, 2025
80FMI \ NEEDLE, HYPODERMIC, SINGLE LUMEN
- Division of Southeast Imports (DSEI)Apr 1, 2025
80KZH \ INTRODUCER, SYRINGE NEEDLE
- Division of Southeast Imports (DSEI)Dec 4, 2024
80NGT \ DEVICE, FLUSH, VASCULAR ACCESS
- Division of Southeast Imports (DSEI)Nov 6, 2024
80FMF \ SYRINGE, PISTON
- Division of Southeast Imports (DSEI)Oct 29, 2024
80FMF \ SYRINGE, PISTON
- Division of Southeast Imports (DSEI)Feb 27, 2024
77KCP \ SYRINGE, ENT